Keyword: Institute of Biomedicine

Students graduating this spring from the Degree Programme in Biomedicine at the Faculty of Medicine of the University of Turku will present their Bachelor’s theses at the Terveydeksi - New Discoveries 2025! thesis seminar. In addition, students from the Drug Discovery and Development and Biomedical Imaging tracks of the Biomedical Sciences Master's programme and students from the Human Neuroscience Master's programme will present their Master's theses at the seminar. Some of the Biomedical Imaging students are from Åbo Akademi University.

A multicentre study led from Finland has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective drug to improve the outcomes of the transfer treatment continues to be sought. 

The European Commission has appointed a European Reference Laboratory to support the control and monitoring of pertussis and diphtheria in the EU/EEA countries. The University of Turku will lead and coordinate the laboratory, which includes five institutes in four countries.

How can sensitive health data be used responsibly in scientific research or how can artificial intelligence help make breakthroughs in medical research? The ECCB2024 conference brings together current themes in computational biology and international researchers in Turku, Finland. 

SYS-LIFE postdoctoral programme announced the selected fellows and their projects for the first call of the programme. The next call will be opened during autumn 2024.

A new Finnish study from University of Turku shows that already a 30-minute exercise can increase the proportion of tumor-killing white blood cells in the bloodstream of breast cancer patients.

Researchers at the University of Turku in Finland have found a new function for an existing protein. They discovered that TIMP-1, a protein traditionally known to prevent damage to the body's cells and tissues, plays a critical role in the immune system's defence against cancer. The findings of the study could improve the effectiveness of current cancer immunotherapies.

Discoveries made when biology meets computational sciences are revolutionising the landscape of life sciences and healthcare. Computational biology and bioinformatics are driving this transformation, helping researchers analyse vast amounts of biological data. European Conference on Computational Biology (ECCB) is Europe’s main event in computational biology and bioinformatics this year, bringing 600–800 experts to Turku, Finland, on 16–20 September 2024.